Changes in Gray Matter Volume and Functional Connectivity in Dementia with Lewy Bodies Compared to Alzheimer's Disease and Normal Aging: Implications for Fluctuations

Overview

Journal Alzheimers Res Ther

Date 2020 Jan 8

PMID 31907068

Citations 11

Authors

Elena Chabran

Vincent Noblet

Paulo Loureiro de Sousa

Catherine Demuynck

Nathalie Philippi

Catherine Mutter

Pierre Anthony

Catherine Martin-Hunyadi

Benjamin Cretin

Frederic Blanc

Affiliations

Soon will be listed here.

Abstract

Background: Fluctuations are one of the core clinical features characterizing dementia with Lewy bodies (DLB). They represent a determining factor for its diagnosis and strongly impact the quality of life of patients and their caregivers. However, the neural correlates of this complex symptom remain poorly understood. This study aimed to investigate the structural and functional changes in DLB patients, compared to Alzheimer's disease (AD) patients and healthy elderly subjects, and their potential links with fluctuations.

Methods: Structural and resting-state functional MRI data were collected from 92 DLB patients, 70 AD patients, and 22 control subjects, who also underwent a detailed clinical examination including the Mayo Clinic Fluctuation Scale. Gray matter volume changes were analyzed using whole-brain voxel-based morphometry, and resting-state functional connectivity was investigated using a seed-based analysis, with regions of interest corresponding to the main nodes of the salience network (SN), frontoparietal network (FPN), dorsal attention network (DAN), and default mode network (DMN).

Results: At the structural level, fluctuation scores in DLB patients did not relate to the atrophy of insular, temporal, and frontal regions typically found in this pathology, but instead showed a weak correlation with more subtle volume reductions in different regions of the cholinergic system. At the functional level, the DLB group was characterized by a decreased connectivity within the SN and attentional networks, while the AD group showed decreases within the SN and DMN. In addition, higher fluctuation scores in DLB patients were correlated to a greater connectivity of the SN with the DAN and left thalamus, along with a decreased connectivity between the SN and DMN, and between the right thalamus and both the FPN and DMN.

Conclusions: Functional connectivity changes, rather than significant gray matter loss, could play an important role in the emergence of fluctuations in DLB. Notably, fluctuations in DLB patients appeared to be related to a disturbed external functional connectivity of the SN, which may lead to less relevant transitions between different cognitive states in response to internal and environmental stimuli. Our results also suggest that the thalamus could be a key region for the occurrence of this symptom.

Citing Articles

The role of on cognitive impairment in Parkinson's disease and Parkinsonisms.

Rosal A, Martin S, Strafella A Front Neurosci. 2025; 19:1515374.

PMID: 40052092 PMC: 11882537. DOI: 10.3389/fnins.2025.1515374.

Functional Connectivity Changes Associated With Depression in Dementia With Lewy Bodies.

Querry M, Botzung A, Sourty M, Chabran E, Sanna L, Loureiro de Sousa P Int J Geriatr Psychiatry. 2025; 40(3):e70058.

PMID: 40011213 PMC: 11865007. DOI: 10.1002/gps.70058.

Aβ42 biomarker linked to insula, striatum, thalamus and claustrum in dementia with Lewy bodies.

Gabriel V, Bousiges O, Mondino M, Cretin B, Philippi N, Muller C Geroscience. 2025; .

PMID: 39821801 DOI: 10.1007/s11357-025-01513-z.

Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia.

Piramide N, De Micco R, Siciliano M, Silvestro M, Tessitore A Curr Neurol Neurosci Rep. 2024; 24(10):461-477.

PMID: 39046642 PMC: 11415422. DOI: 10.1007/s11910-024-01365-8.

Neuroanatomical substrates of depression in dementia with Lewy bodies and Alzheimer's disease.

Querry M, Botzung A, Cretin B, Demuynck C, Muller C, Ravier A Geroscience. 2024; 46(6):5725-5744.

PMID: 38750385 PMC: 11493943. DOI: 10.1007/s11357-024-01190-4.

References

Francis P, Perry E . Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Mov Disord. 2008; 22 Suppl 17:S351-7. DOI: 10.1002/mds.21683. View

Crone J, Soddu A, Holler Y, Vanhaudenhuyse A, Schurz M, Bergmann J . Altered network properties of the fronto-parietal network and the thalamus in impaired consciousness. Neuroimage Clin. 2014; 4:240-8. PMC: 3895618. DOI: 10.1016/j.nicl.2013.12.005. View

OBrien J, Firbank M, Mosimann U, Burn D, McKeith I . Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res. 2005; 139(2):79-88. DOI: 10.1016/j.pscychresns.2005.04.002. View

Fernandez-Espejo D, Soddu A, Cruse D, Palacios E, Junque C, Vanhaudenhuyse A . A role for the default mode network in the bases of disorders of consciousness. Ann Neurol. 2012; 72(3):335-43. DOI: 10.1002/ana.23635. View

Watson R, Colloby S, Blamire A, Wesnes K, Wood J, OBrien J . Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies?. Parkinsonism Relat Disord. 2017; 45:69-74. DOI: 10.1016/j.parkreldis.2017.10.006. View

Bradshaw J, Saling M, Hopwood M, Anderson V, Brodtmann A . Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct. J Neurol Neurosurg Psychiatry. 2004; 75(3):382-7. PMC: 1738966. DOI: 10.1136/jnnp.2002.002576. View

Perry E, Morris C, Court J, Cheng A, Fairbairn A, McKeith I . Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 1995; 64(2):385-95. DOI: 10.1016/0306-4522(94)00410-7. View

McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

Tiraboschi P, Hansen L, Alford M, Merdes A, Masliah E, Thal L . Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry. 2002; 59(10):946-51. DOI: 10.1001/archpsyc.59.10.946. View

10.

Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein H, Vermersch P . Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992; 55(10):967-72. PMC: 1015202. DOI: 10.1136/jnnp.55.10.967. View

11.

Uddin L . Salience processing and insular cortical function and dysfunction. Nat Rev Neurosci. 2014; 16(1):55-61. DOI: 10.1038/nrn3857. View

12.

Zweig Y, Galvin J . Lewy body dementia: the impact on patients and caregivers. Alzheimers Res Ther. 2014; 6(2):21. PMC: 4054937. DOI: 10.1186/alzrt251. View

13.

Wang Z, Xia M, Dai Z, Liang X, Song H, He Y . Differentially disrupted functional connectivity of the subregions of the inferior parietal lobule in Alzheimer's disease. Brain Struct Funct. 2013; 220(2):745-62. DOI: 10.1007/s00429-013-0681-9. View

14.

Zhou J, Seeley W . Network dysfunction in Alzheimer's disease and frontotemporal dementia: implications for psychiatry. Biol Psychiatry. 2014; 75(7):565-73. DOI: 10.1016/j.biopsych.2014.01.020. View

15.

OBrien J, Colloby S, Fenwick J, Williams E, Firbank M, Burn D . Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004; 61(6):919-25. DOI: 10.1001/archneur.61.6.919. View

16.

Hellyer P, Shanahan M, Scott G, Wise R, Sharp D, Leech R . The control of global brain dynamics: opposing actions of frontoparietal control and default mode networks on attention. J Neurosci. 2014; 34(2):451-61. PMC: 3870930. DOI: 10.1523/JNEUROSCI.1853-13.2014. View

17.

Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M . EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain. 2008; 131(Pt 3):690-705. DOI: 10.1093/brain/awm322. View

18.

Burton E, Karas G, Paling S, Barber R, Williams E, Ballard C . Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage. 2002; 17(2):618-30. View

19.

Aarsland D, Mosimann U, McKeith I . Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2004; 17(3):164-71. DOI: 10.1177/0891988704267463. View

20.

Perry E, Walker M, Grace J, Perry R . Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends Neurosci. 1999; 22(6):273-80. DOI: 10.1016/s0166-2236(98)01361-7. View